Sam Hartzmark from Boston College sat for Meb Faber's latest pod where they explored the flawed thinking people have regarding dividends. Listen to the pod but I think I can sum it up with a poll that Meb ran earlier in the week. Essentially, a lot of investors don't understand how the ex-dividend process works. If a $100 stock pays a $1 dividend, you still have the same $100 of total value. The day before the ex-date the total value was the price of the stock, $100. After the ex-date, you still have $100 total value comprised of $99's worth of stock and $1 worth of dividends.
People also muddy their own waters, according to the conversation, using total return and price return incorrectly. If people spend all of their dividends, then the return leftover, available to make the account grow will be much less. That is important to understand for anyone taking their dividends out.
Many years ago I referred to the "dividend zealots" that dominated Seeking Alpha content and comments. That group was probably a magnified version of the attachment and mental accounting that goes with dividends. We looked recently and some whistling past the graveyard about how "good dividend stocks" can take bad turns or some of the tax inefficiencies when dividends aren't qualified. Sam and Meb also tackled the underwhelming nature of dividend centric funds, even dividend growth centric funds but listen and draw your own conclusion.
On a similar track, here's this exchange about derivative income funds.
This from me about covered call funds.
The difference between the total return and the price only return supports the point made from the podcast. Anyone buying ISPY (in my ownership universe) or SPYI is not getting the S&P 500 if they take out all of the dividends. This isn't a problem for people who understand the mechanics. The pitch for covered call fund of upside with downside protection tends to be overstated.
With the proper understanding of how they work, taking out all the of the distribution and still getting a few hundred basis points of price-only return is a pretty good outcome when sized appropriately (small) as one of many distinct income streams but it's not capturing the index, repeated for emphasis.
Here's a YieldMax fund that we haven't looked at before but is similar to many crazy high yielders.
TSMY's total return lags meaningfully behind the common stock because it is not the common stock. TSMY has paid out about 55% based on this chart. As we have seen with other YieldMax products, it makes sense to expect that at some point, TSMY will do a reverse split. The bleed thus far is TSMY hasn't been that bad but that is because the common is up more than 60%.
If the common had only been up 25%, would TSMY be down 30%? It's probably not that linear but you get the idea. It's less problematic when people understand this. Knowing how it works and buying it anyway that yields 55% might not be optimal but based on the many comments that YieldMax gets about this issue on Twitter, a lot of people don't understand, speaks to one of the ideas Meb and Sam discussed.
The crazy high yielders are better thought of as products that sell the volatility of their respective reference securities.
Following up on MHIP and MHIG that we mentioned yesterday. Copilot was able to find some holdings and asset allocation information.
So they are multi-asset and seem to be quadrant inspired. The funds are heavy to health-related companies but not exclusively invested in that sector. Maybe the idea with the overweight to healthcare is that since the healthcare system will cost a lot, the funds make the healthcare companies cover fundholders' medical costs.
The information, analysis and opinions expressed herein reflect our judgment and opinions as of the date of writing and are subject to change at any time without notice. They are not intended to constitute legal, tax, securities or investment advice or a recommended course of action in any given situation.